Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to
HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guidebreast cancer treatment. This evidence concerns the gene ERBB2 and cancer.